The newest Dream Horse, Voltarion, is at the center of the latest Black Desert Online update, out today. The Snowfall Crasher event also opens, bringing rewarding seasonal activities to the ...

Newton Emerson’s curt and dismissive response to our call for an Irish passport office in the north, to deal with huge demand, merits a challenge. Firstly, Mr Emerson seems to not understand ...

Ever wondered what goes into crafting the legendary Air Jordan 3 Black Cat sneakers? From premium materials to cutting-edge technology, the process is a true masterpiece! Stephen King Urges Oscars ...

Well, it turns out that the passport tucked into your travel wallet can either be a golden ticket or a bit of a bureaucratic speed bump. As 2025 rolls in, the Henley Passport Index is here to ...

Michigan late-stage biopharma, Sling Therapeutics, said a Phase IIb/III LIDS trial of its oral small molecule therapy designed to treat thyroid eye disease (TED) met its primary endpoint.

“Tidy dynamics and an upmarket cabin make the Mazda 3 a top-notch hatch, even if it is a bit poky” Mazda is into simplicity, on the whole. Just two petrol engines are available: a 2.5-litre ...

Credit: Shutterstock /Garna Zarina Michigan late-stage biopharma, Sling Therapeutics, said a Phase IIb/III LIDS trial of its oral small molecule therapy designed to treat thyroid eye disease (TED) met ...

The new interface for DIsh Network’s streaming TV service Sling TV. (Graphic by The Desk) Echostar-owned streaming television service Sling TV has debuted an unlimited cloud DVR feature that allows ...

MANILA, Philippines — In a world where the odds are stacked against the Philippine passport, Kach Umandap has carved a path of possibility, proving that borders can be crossed with courage and ...

Sling Therapeutics’ oral challenger to Amgen’s intravenous Tepezza has hit the mark in a phase 2b/3 thyroid eye disease (TED) trial, teeing the biotech up to run a confirmatory study of its ex ...

US late-stage biopharma firm Sling Therapeutics today announced top-line efficacy and safety data from the Phase IIb/III LIDS trial of linsitinib in patients with active, moderate to severe thyroid ...